|
Market Closed -
NYSE
16:00:02 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 51.50 USD | -2.52% |
|
+16.28% | +26.85% |
| 10-29 | CONMED Corporation, Q3 2026 Earnings Call, Oct 28, 2026 | |
| 10-28 | Earnings Flash (CNMD) CONMED Corporation Reports Q3 Revenue $335.6M, vs. FactSet Est of $336.3M | MT |
Company Valuation: CONMED Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,146 | 2,702 | 3,368 | 2,114 | 1,257 | 1,535 | - | - |
| Change | - | -34.83% | 24.64% | -37.22% | -40.53% | 22.08% | - | - |
| Enterprise Value (EV) 1 | 4,810 | 3,728 | 4,317 | 2,995 | 2,051 | 2,277 | 2,180 | 2,067 |
| Change | - | -22.5% | 15.81% | -30.62% | -31.52% | 11.01% | -4.25% | -5.21% |
| P/E | 73.1x | -33.1x | 53.7x | 16.1x | 26.9x | 13.6x | 11.4x | 11.1x |
| PBR | 5.26x | 3.57x | 4.04x | 2.2x | 1.1x | 1.36x | 1.19x | 1.05x |
| PEG | - | 0x | -0x | 0x | -0.4x | 0x | 0.6x | 4.01x |
| Capitalization / Revenue | 4.1x | 2.58x | 2.71x | 1.62x | 0.91x | 1.13x | 1.08x | 1.02x |
| EV / Revenue | 4.76x | 3.57x | 3.47x | 2.29x | 1.49x | 1.67x | 1.53x | 1.38x |
| EV / EBITDA | 24.4x | 19.8x | 18.3x | 11.3x | 7.44x | 8.04x | 7.36x | 6.73x |
| EV / EBIT | 33.6x | 28.4x | 24.8x | 14.8x | 9.5x | 10.5x | 9.55x | 8.39x |
| EV / FCF | 49.6x | 322x | 40.6x | 19.5x | 13.6x | 10.6x | 13.3x | 12.4x |
| FCF Yield | 2.01% | 0.31% | 2.46% | 5.14% | 7.36% | 9.44% | 7.55% | 8.08% |
| Dividend per Share 2 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | - | - | - |
| Rate of return | 0.56% | 0.9% | 0.73% | 1.17% | 1.97% | - | - | - |
| EPS 2 | 1.94 | -2.68 | 2.04 | 4.25 | 1.51 | 3.79 | 4.515 | 4.64 |
| Distribution rate | 41.2% | -29.9% | 39.2% | 18.8% | 53% | - | - | - |
| Net sales 1 | 1,011 | 1,045 | 1,245 | 1,307 | 1,375 | 1,363 | 1,426 | 1,500 |
| EBITDA 1 | 197.2 | 188.7 | 235.4 | 265.6 | 275.9 | 283.2 | 296.3 | 307 |
| EBIT 1 | 143.3 | 131.3 | 174.4 | 202.8 | 216 | 216.6 | 228.4 | 246.2 |
| Net income 1 | 62.54 | -80.58 | 64.46 | 132.4 | 47.06 | 114.4 | 136.8 | 140.4 |
| Net Debt 1 | 663.8 | 1,026 | 949.6 | 881.3 | 794.1 | 742.4 | 645.6 | 532 |
| Reference price 2 | 141.76 | 88.64 | 109.51 | 68.44 | 40.60 | 51.50 | 51.50 | 51.50 |
| Nbr of stocks (in thousands) | 29,247 | 30,482 | 30,752 | 30,891 | 30,968 | 29,803 | - | - |
| Announcement Date | 1/26/22 | 2/2/23 | 1/31/24 | 2/5/25 | 1/28/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 13.94x | 1.7x | 8.18x | -.--% | 1.57B | |
| 37.58x | 4.41x | 16.56x | 2.28% | 197B | |
| 22.7x | 3.83x | 13.73x | 2.7% | 128B | |
| 28.76x | 5.12x | 17.49x | 1.08% | 128B | |
| 33.69x | 3.23x | 13.02x | 2.12% | 99B | |
| 18.02x | 0.21x | 13.44x | 0.7% | 64.82B | |
| 43.53x | 3.84x | 13.07x | 1.96% | 58.17B | |
| 45.13x | 11.18x | 31.39x | -.--% | 52.84B | |
| 28.95x | 7.16x | 18.29x | 1.39% | 50.69B | |
| 45.64x | 3.6x | 13.37x | 0.48% | 37.23B | |
| Average | 31.79x | 4.43x | 15.85x | 1.27% | 81.7B | |
| Weighted average by Cap. | 32.54x | 4.48x | 16.24x | 1.7% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CNMD Stock
- Valuation CONMED Corporation
Select your edition
All financial news and data tailored to specific country editions
